Differential crosslinking of histones and non-histones in nuclei by cis-Pt(II)  by Filipski, Jan et al.
Volume 152, number 1 FEBS LETTERS February 1983 
Differential crosslinking of histones and non-histones in nuclei 
by cis-Pt(I1) 
Jan Filipski, Kurt W. Kohn and William M. Bonner 
Laboratory of Molecular Pharmacology, Developmental Therapeutics Program, Division of Cancer Treatment, 
National Cancer Institute, National Institutes of Health, Bethesda, MD 20205, USA 
Received 17 December 1982 
When nuclei were treated with the chemotherapeutic agent, cis-Pt(II), they were crosslinked to the extent 
that their nuclear morphology as assayed by light microscopy was retained even in the presence of SDS. 
Protein analysis showed that the histones were completely absent from these nuclear structures, while the 
non-histone proteins, with one possible exception, were completely retained. When the nuclear structures 
in SDS were treated with thiourea to reverse the crosslinks, the non-histone proteins were liberated and 
the nuclear structures disappeared. When treated with Proteinase K in SDS, the nuclear structures also 
disappeared, indicating that protein components were necessary to maintain the structures. 
Histone Non-histone 
1. INTRODUCTION 
Crosslinking reagents comprise an important 
group of chemotherapeutic agents. Their ability to 
form DNA inter-strand crosslinks is well documen- 
ted (see Ludlum [I] for review). In addition, vari- 
ous studies have suggested that protein is bound to 
the DNA after treatment of nuclei or cells [2-71 
with various crosslinking agents. Thomas et al. [8] 
characterized the proteins crosslinked to DNA by 
nitrogen mustard treatment. Those proteins were 
released from the DNA by the same conditions 
that released alkylated purines, results which indi- 
cated that they were originally linked through die- 
thylamino moieties to the DNA. When analyzed by 
SDS gel electrophoresis, the released proteins were 
found to be a subset of the non-histone proteins. 
In this paper, we investigate the effects of cis- 
Pt(I1) on nuclei. This reagent seems to crosslink 
the non-histone proteins and the DNA into a 
lattice-work structure which retains an overall nu- 
clear morphology in the light microscope even af- 
ter SDS treatment. In contrast the histones were 
not crosslinked to this structure, and could be re- 
moved by SDS extraction. 
Nucleus Cis-Pt(II) 
2. MATERIALS AND METHODS 
Mouse L1210 cells were grown, labeled with 
[14C]leucine (New England Nuclear) and [3H]thy- 
midine (New England Nuclear) as previously desc- 
ribed [8]. Nuclei, isolated by a detergent method 
[9] as modified by Thomas et al. [8], were suspen- 
ded in HCS buffer (10 mM HEPES, pH 6.4, 
1 mM CaCl2, 0.32 M sucrose). Cis- or trans-Pt(II), 
which had been dissolved in HCS for at least 1 h 
before use was added to the nuclear suspension, 
which was incubated at 37°C for various periods 
of time. 
For CsCl centrifugation, the solution containing 
the treated nuclei was dialyzed against 0.02 M 
EDTA-0.05 M Tris-HCl (pH 7), then briefly so- 
nicated (5 s, setting 1 of a Branson S125 sonifier 
using a microtip), adjusted to 0.3% Sarcosyl and 
layered over 3.0 ml of 3.0 M CsCl solution (36.7% 
CsCl by weight, 0.02 M EDTA, 0.05 M Tris-HCl, 
0.3% Sarcosyl, pH 7) and centrifuged in a SW 56 
rotor at 40000 rev./min for 23 h at 4°C. 
For the analysis of proteins crosslinked in the 
nuclear structures, 1.5 x 10’ nuclei were treated 
with 1 mM cis-Pt(I1) in HCS buffer for 1 h at 
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37”C, then washed with HCS to remove remaining 
drug. The treated nuclei were extracted with 0.1 ml 
1% SDS, washed twice more with 1% SDS, then 
incubated in 0.1 ml 1 M thiourea for 1 h at 37°C 
[lo]. The SDS and thiourea extracts were loaded 
onto an SDS gel and the proteins analyzed as desc- 
ribed previously [ 11,121. 
3. RESULTS 
3.1. CsCl centrifugation 
When isolated nuclei were dissolved in 0.3% 
Sarcosyl and centrifuged through 3.0 M CsCl, less 
than 0.1% of the radioactivity ([14C]leucine) pre- 
sent in nuclei was found in the pellet (bottom 
0.7 ml of tube) while DNA recovery in the pellet 
was over 90%. When the nuclei were incubated 
first with cis-Pt(II), most of the DNA did not pellet 
through CsCl as it did in the control, but was dis- 
tributed in several bands in the gradient (fig.1). 
Protein was also found coincident with the DNA 
bands, but most was at the top of the gradient. 
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FRACTION 
The proteins bound in the nuclear structures had 
to be released before analysis. Filipski et al. [lo] 
had shown that thiourea reverses DNA-DNA 
crosslinks made by cis and trans-Pt(I1). Since the 
bond between Pt(I1) and DNA is presumably the 
same in a DNA-DNA crosslink and a 
DNA-protein crosslink, thiourea was used to re- 
lease proteins from the nuclear structures. When 
thiourea was added to the nuclear structures in 
SDS, they rapidly disappeared and the solution be- 
came quite viscous, indicating that the DNA had 
remained intact. The proteins released by thiourea 
treatment were analyzed by gel electrophoresis and 
their profile was found to be virtually identical 
with the non-histone portion (fig.2, middle trace) 
of the control profile (top trace). No histones were 
present in this fraction; they seem to have all been 
removed by the SDS treatment prior to the thiou- 
rea treatment. 
Fig. 1. Equilibrium centrifugation of cis-Pt(II)-treated 
nuclei in 3.0 M CsCl. L1210 nuclei, labeled with 
[3H]thymidine and [‘4C]leucine were treated in HCS 
buffer with 1 mM cis-Pt(II) for 1 h at 20°C. Unreacted 
compound was removed by washing the nuclei with HCS 
buffer. Nuclei were then processed through 3.0 M CsCl 
as described in the text. These nuclear structures, stable in SDS, seem to 
More striking was the finding that in the light mi- 
croscope, structures with nuclear morphology 
could be seen in fraction 7 and structures with nu- 
cleolar morphology could be seen in fraction 10, 
even though these gradients contained 0.3% Sarco- 
syl and 3 M CsCl to disrupt all noncovalent bonds. 
We concluded from this experiment hat cis-Pt(I1) 
had at least partially fixed these nuclei, but that at 
the same time much of the protein had been relea- 
sed to the top of the gradient. 
The data presented in fig.1 were obtained with 
nuclei treated with 1 mM cis-Pt(I1) for 1 h. Lower 
concentrations of cis-Pt(I1) were effective but re- 
quired longer incubations. The trans isomer was 
also tested and was found to be somewhat more ef- 
ficient than cis-Pt(I1) in this regard; 0.3 mM trans- 
Pt(I1) for 1 h fixed nuclei to approximately the sa- 
me extent as did 1 mM cis-Pt(I1) for 1 h. 
3.2. Protein analysis 
In order to investigate the nature of these nu- 
clear structures, the bound and unbound proteins 
were compared by gel electrophoresis. Since cis- 
Pt(I1) partially fixes the nuclei, the unlinked pro- 
teins could easily be extracted from them with 1% 
SDS. Centrifugation at 100 x g for 5 min peileted 
the nuclear structures. Figure 2 shows that the SDS 
extract (bottom trace) contained histones in about 
the same amount as the control (top trace), but few 
if any non-histone proteins were present. 
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Fig.2. SDS gel analysis of proteins released from cis- 
Pt(I1) treated nuclei. Unlabeled nuclei were treated as in 
fig.1. After washing to remove unreacted compound, 
the fixed nuclei were extracted three times with 1% SDS 
to remove any proteins that were not covalently bound. 
The pellet from the third SDS wash was suspended in 
1 M thiourea and incubated for 1 h at 37°C. During this 
incubation the fixed nuclei dissolved and the solution 
became quite viscous. The traces record the density of 
protein stain. (Top truce) Control. Histones are denoted 
on this trace. (Middle truce) Proteins released from SDS 
pellet after thiourea treatment. (Bottom trace) Proteins 
in SDS extract before thiourea treatment. 
have retained virtually all the non-histone proteins 
but virtually none of the histones. Only two com- 
ponents seemed to be common to both the bound 
and unbound fractions. Both migrated between 
HlB and H3, and were found predominantly but 
not totally in the histone fraction. The faster peak 
comigrated with the ubiquitin adduct of histone 
2A. Ubiquitin is a protein with A4, -8000 and is at- 
tached through its carboxy terminal to lysine 119 in 
H2A. The equilibrium between ubiquitin and H2A 
is rapidly reversible [ 131, suggesting that the ubi- 
quitin is not tightly associated with the DNA. This 
protein is therefore a hybrid, part histone, part 
non-histone. Ubiquitinated H2A could have been 
crosslinked through its ubiquitin moiety and for 
that reason found partly in the non-histone fracti- 
on. Any crosslinking would probably have been 
through the ubiquitin moiety since H2A itself was 
not found in the nonhistone fraction. The other 
protein found in this region seemed to comigrate 
with HMG 1. Also we cannot exclude the possibili- 
ty that other minor non-histone proteins, not de- 
tected by mass, might be present in both the bound 
and unbound fractions. 
The results from the CsCl gradient show that 
protein and DNA were both present in the nuclear 
structures resulting from cis-Pt(I1) treatment. The 
disappearance of these structures after thiourea 
treatment indicated that cis-Pt(I1) crosslinks were 
involved in maintaining the structures in the pre- 
sence of SDS or Sarcosyl. Because cis-Pt(I1) can 
cause DNA-DNA, DNA-protein, and 
protein-protein crosslinks, we tested whether the 
protein molecules were essential in maintaining the 
nuclear structures. Proteinase K, a proteolytic en- 
zyme that can digest protein in the presence of 
SDS, was added to the cis-Pt(I1) treated nuclei in 
SDS. The nuclear structures rapidly disappeared, a 
result which indicated that at least a fraction of the 
non-histone protein was necessary for the mainte- 
nance of such structures. 
4. DISCUSSION 
This report shows that cis-Pt(I1) can crosslink 
non-histone nuclear components so that nuclear 
structures are maintained in the presence of SDS. 
The finding that the histones can be quantitatively 
extracted indicates that the non-histone proteins 
are not just trapped in a gel network, but are cova- 
lently bound either to the DNA or to each other. 
To make a crosslinked structure that still maintains 
a nuclear morphology in SDS, it is necessary that 
at least some of the components be crosslinked at 
several sites. 
Lippard and Hoeschele [14] studied the binding 
of cis and trans-Pt(I1) to nucleosome cores which 
contained no non-histone proteins. They found 
that the cis isomer made a small amount of 
histone-histone and histone-DNA crosslinks, but 
only with incubation times considerably longer 
than the ones used in this report. We saw no indi- 
cation of any histone crosslinking with cis-Pt(I1) in 
nuclei under our experimental conditions, even 
though at the same time virtually all the non- 
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histone proteins were crosslinked into the nuclear 
structures. 
What could be the molecular basis of the diffe- 
rential crosslinking of histones and non-histones? 
One possibility concerns the presence or absence of 
cysteine residues. Among the histones, only H3 has 
cysteine residues but these are buried and therefore 
non-reactive [151. The possible presence of cysteine 
residues in the non-histones may be one factor lea- 
ding to much faster Pt binding to these proteins. If 
most of the non-histone proteins are already invol- 
ved in tubules, filaments, nuclear matrix, chromo- 
some scaffold, nuclear membrane structures or 
other very large multisubunit complexes they may 
be very rapidly crosslinked by cis-Pt(I1) to structu- 
res stable in denaturing solvents. There is some evi- 
dence that many if not most nucleoplasmic pro- 
teins may be weakly bound to nuclear sites, even 
though these may not be the ultimately functional 
ones [16]. Factors such as these could lead to the 
striking differences in reactivity between histones 
and non-histones described in this report. 
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